Invasion as target for therapy of glioblastoma multiforme

作者: Anne Vehlow , Nils Cordes

DOI: 10.1016/J.BBCAN.2013.07.001

关键词:

摘要: The survival of cancer patients suffering from glioblastoma multiforme is limited to just a few months even after treatment with the most advanced techniques. indefinable borders cell infiltration into surrounding healthy tissue prevent complete surgical removal. In addition, genetic mutations, epigenetic modifications and microenvironmental heterogeneity cause resistance radio- chemotherapy altogether resulting in hardly overcome therapeutic scenario. Therefore, development efficient strategies combat these tumors requires better knowledge proteomic alterations as well infiltrative behavior cells how this can be targeted. Among many surface receptors, members integrin family are known regulate invasion concert extracellular matrix degrading proteases. While preclinical early clinical trials suggested specific targeting promising approach, failed deliver improved cure rates up now. Little about motility, but switches modes adaption cues consequence may maintain tumor therapy. Thus, understanding molecular basis protease function for context radiochemotherapy pressing issue beneficial design approaches. This review article summarizes latest findings on integrins adds some perspective thoughts might exploited optimized multimodal therapy

参考文章(179)
F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, L. Chin, R. A. DePinho, W. K. Cavenee, Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes & Development. ,vol. 21, pp. 2683- 2710 ,(2007) , 10.1101/GAD.1596707
Flavia RS Lima, Suzana Assad Kahn, Rossana C Soletti, Deborah Biasoli, Tercia Alves, Anna Carolina C da Fonseca, Celina Garcia, Luciana Romão, José Brito, Rosenilde Holanda-Afonso, Jane Faria, Helena Borges, Vivaldo Moura-Neto, None, Glioblastoma: therapeutic challenges, what lies ahead. Biochimica et Biophysica Acta. ,vol. 1826, pp. 338- 349 ,(2012) , 10.1016/J.BBCAN.2012.05.004
C.L. Gladson, D.A. Cheresh, J.N. Wilcox, G.Y. Gillespie, L. Sanders, Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. Journal of Cell Science. ,vol. 108, pp. 947- 956 ,(1995) , 10.1242/JCS.108.3.947
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin JB Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger, Peter Hau, Alba A Brandes, Johanna Gijtenbeek, Christine Marosi, Charles J Vecht, Karima Mokhtari, Pieter Wesseling, Salvador Villa, Elizabeth Eisenhauer, Thierry Gorlia, Michael Weller, Denis Lacombe, J Gregory Cairncross, René-Olivier Mirimanoff, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncology. ,vol. 10, pp. 459- 466 ,(2009) , 10.1016/S1470-2045(09)70025-7
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues, None, The 2007 WHO Classification of Tumours of the Central Nervous System Acta Neuropathologica. ,vol. 114, pp. 97- 109 ,(2007) , 10.1007/S00401-007-0243-4
Stephanie E Combs, Iris Burkholder, Lutz Edler, Stefan Rieken, Daniel Habermehl, Oliver Jäkel, Thomas Haberer, Renate Haselmann, Andreas Unterberg, Wolfgang Wick, Jürgen Debus, Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial BMC Cancer. ,vol. 10, pp. 533- 533 ,(2010) , 10.1186/1471-2407-10-533
Hana Janouskova, Anne Maglott, David Y. Leger, Catherine Bossert, Fanny Noulet, Eric Guerin, Dominique Guenot, Sophie Pinel, Pascal Chastagner, François Plenat, Natacha Entz-Werle, Jacqueline Lehmann-Che, Julien Godet, Sophie Martin, Jan Teisinger, Monique Dontenwill, Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. Cancer Research. ,vol. 72, pp. 3463- 3470 ,(2012) , 10.1158/0008-5472.CAN-11-4199
Roel GW Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov, Gabriele Alexe, Michael Lawrence, Michael O'Kelly, Pablo Tamayo, Barbara A Weir, Stacey Gabriel, Wendy Winckler, Supriya Gupta, Lakshmi Jakkula, Heidi S Feiler, J Graeme Hodgson, C David James, Jann N Sarkaria, Cameron Brennan, Ari Kahn, Paul T Spellman, Richard K Wilson, Terence P Speed, Joe W Gray, Matthew Meyerson, Gad Getz, Charles M Perou, D Neil Hayes, None, Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell. ,vol. 17, pp. 98- 110 ,(2010) , 10.1016/J.CCR.2009.12.020
Natalya M. Khazenzon, Alexander V. Ljubimov, Julia Y. Ljubimova, Ismo Virtanen, Hironobu Fujiwara, Noora Petäjäniemi, Keith L. Black, Kiyotoshi Sekiguchi, Lydia M. Sorokin, Manabu Fujita, Alexander J. Lakhter, Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro Molecular Cancer Therapeutics. ,vol. 2, pp. 985- 994 ,(2003)
G. P. Dunn, M. L. Rinne, J. Wykosky, G. Genovese, S. N. Quayle, I. F. Dunn, P. K. Agarwalla, M. G. Chheda, B. Campos, A. Wang, C. Brennan, K. L. Ligon, F. Furnari, W. K. Cavenee, R. A. Depinho, L. Chin, W. C. Hahn, Emerging insights into the molecular and cellular basis of glioblastoma Genes & Development. ,vol. 26, pp. 756- 784 ,(2012) , 10.1101/GAD.187922.112